Sales and Marketing

Showing 15 posts of 11528 posts found.

the-chinese-national-flag-1752046_960_720

China’s insurance expansion boon to global pharma

February 23, 2017 Sales and Marketing AstraZeneca, China, GSK, Shire

China has expanded the list of medicines that are covered on basic medical insurance schemes, named China’s National Reimbursement Drug …
egypt_india_locator

Sun Pharma inaugurates first Egypt production facility

February 23, 2017 Manufacturing and Production, Sales and Marketing Egypt, India, Ranbaxy, Sun Pharma

Ranbaxy, a subsidiary of India’s Sun Pharma, has opened its first production facility in Egypt in a bid to further …
celltrion

First biosimilar for European cancer treatment given approval

February 23, 2017 Sales and Marketing biosimilar, celltrion

The first biosimilar will be made available in Europe to match the indications of Roche’s best-selling cancer drug, Rituxan. The …

Novartis’ Zykadia scores priority review and breakthrough designation from FDA

February 23, 2017 Sales and Marketing Novartis, zykadia

Novartis’ lung cancer treatment Zykadia (ceritinib) has been awarded both priority review and breakthrough therapy designation by the US Food …

Insider Interview: BGMA Director Warwick Smith disputes recent generic price increase claims

February 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Warwick Smith, bgma, generics

Warwick Smith, Director of the British Generic Manufacturer’s Association (BGMA), discusses the recent data suggesting generic drug prices in the …
roche__tree

Roche and Discuva extend agreement to develop target antimicrobials

February 22, 2017 Research and Development, Sales and Marketing Discuva, Roche

Discuva, a drug discovery company based in Cambridge, UK, has announced that its collaboration with Roche, first agreed in 2014, …
headshot_ryan

Nativis bolsters boardroom with new director

February 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nativis

Nativis Inc., a clinical stage life science bio-electronic company, has announced the appointment of Dr Una Ryan to its board …
pharmafocus_march_cover

The March 2017 issue of Pharmafocus is now live!

February 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, FDA, Johnson & Johnson, MSD, Roche, Trump, crispr, immunotherapy, opdivo

The latest edition of Pharmafocus is available to read online now! From breakthroughs in antibiotic resistance R&D to gene editing …

FDA Priority Review for Pfizer investigational leukaemia drug

February 22, 2017 Research and Development, Sales and Marketing EMA, FDA, Inotuzumab ozogamicin, Pfizer, priority review

Pfizer has announced that its leukaemia treatment inotuzumab ozogamicin has been accepted for Priority Review by the US Food and …

NICE provisionally rejects Ipsen’s kidney cancer drug Cabometyx

February 21, 2017 Manufacturing and Production, Sales and Marketing Cometriq, NICE, ipsen

NICE has announced draft guidance for Ipsen’s cancer drug Cabometyx (cabozantinib), revealing it does not recommend the drug for use on …
handshake

Amygdala acquires Gilead’s candidate for addiction treatment

February 20, 2017 Manufacturing and Production, Sales and Marketing Amygdala, Gilead

Amygdala Neurosciences, a biopharmaceutical company that develops and commercialises drugs for the treatment of addiction disorders, has agreed an acquisition …

BlackThorn Therapeutics bring in new CEO

February 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BlackThorn Therapeutics

BlackThorn Therapeutics, a biopharmaceutical company that works on developing treatments for neurobehavioral disorders, announced the appointment of Gregory Vontz to …
medication

Generic version of top-selling lung cancer drug hits Chinese market

February 20, 2017 Sales and Marketing China, generics

A generic version of AstraZeneca’s Iressa (gefitinib) has been released onto the Chinese market, named Yiruike. The generic undercuts the …
celgene_1_02

Celgene’s potential blockbuster gets positive Phase 3 results in multiple sclerosis

February 20, 2017 Research and Development, Sales and Marketing Celgene, multiple sclerosis

Celgene’s drug to treat patients suffering with relapsing multiple sclerosis (RMS) was given a boost by positive Phase 3 trial …
heart_image

Cardiovascular disease expected to place $1 trillion cost burden on US

February 20, 2017 Medical Communications, Sales and Marketing cardiovascular disease

A study conducted by RTI International, a non-profit research institute, has warned that the US could have to balance over …
The Gateway to Local Adoption Series

Latest content




Five Facts about COPD

October 11, 2026